← All trials
NCT04924660
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jul 15, 2021
- Primary completion
- May 31, 2022
- Completion date
- Dec 30, 2022
- First posted
- Jun 14, 2021
- Last posted
- Nov 17, 2021
- Enrollment
- 1600
- Arms / groups
- 5 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Vanderbilt UniversityLead sponsor
- National Institutes of Health (NIH)Collaborator
- National Heart, Lung, and Blood Institute (NHLBI)Collaborator
- Vanderbilt UniversitySponsor investigator
- Vanderbilt UniversityStudy chair
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.